| [1] | Zong W., Rahman T., Zhu L., et al. (2023). Transcriptomic congruence analysis for evaluating model organisms. Proc. Natl. Acad. Sci. USA 120:e2202584120. DOI:10.1073/pnas.2202584120 |
| [2] | Mourragui S., Loog M., van de Wiel M.A., et al. (2019). PRECISE: A domain adaptation approach to transfer predictors of drug response from pre-clinical models to tumors. Bioinformatics 35:i510−i519. DOI:10.1093/bioinformatics/btz372 |
| [3] | Zou J., Shah O., Chiu Y.C., et al. (2024). Systems approach for congruence and selection of cancer models towards precision medicine. PLoS Comput. Biol. 20:e1011754. DOI:10.1371/journal.pcbi.1011754 |
| [4] | Laubenbacher R., Mehrad B., Shmulevich I., et al. (2024). Digital twins in medicine. Nat. Comput. Sci. 4:184−191. DOI:10.1038/s43588-024-00607-6 |
| [5] | Jentzsch V., Osipenko L., Scannell J.W., et al. (2023). Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors. JAMA Netw. Open 6:e2324977. DOI:10.1001/jamanetworkopen.2023.24977 |
| Hu Y., Zong W., Wang J., et al. (2026). Redefining the tumor digital twin through cross-domain manifold mapping. The Innovation Oncology 1:100012. https://doi.org/10.59717/j.xinn-oncol.2026.100012 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Conceptual overview of the Cell-Line-Like-Me framework